上皮性卵巢癌预后因素的研究进展

卵巢癌是女性生殖系统中最常见的肿瘤之一，其中上皮性卵巢癌是卵巢癌最常见的病理类型。约70%的上皮性卵巢癌患者被诊断时已经是晚期，因此早发现、早诊断、早治疗是提高上皮性卵巢癌患者生存率的重要方法之一。上皮性卵巢癌的标准治疗方式为细胞瘤减灭术及铂类为主的化疗，但是随着肿瘤细胞对化疗产生耐药性大多数患者在医治后容易复发，患者存活率一般都很低并且疾病很难控制。近年来，对上皮性卵巢癌发病的分子机制的研究不断进展，发现了更多影响上皮性卵巢癌预后的因素，并且可作为潜在的治疗靶点提高患者生存率。

Research progress on prognostic factors of epithelial ovarian cancer

Ovarian cancer is one the most common type of tumor among the tumor of female reproductive system，and epithelial ovarian cancer is one of the most familiar pathological patterns.It shows that about 70 percent of the patients with epithelial ovarian cancer were in the final stage of the cancers when they were diagnosed.Therefore，to enhance the survival rate of the patient with epithelial ovarian cancer，a early finding，diagnosing and treating would contribute to healing the cancer.The standard treatment for epithelial ovarian cancer is cytoma reduction and platinum-based chemotherapy，but with the development of resistance of tumor cells to chemotherapy，most patients are prone to recurrence after treatment，and the survival rate of patients is generally very low and the disease is difficult to control.In recent years，the research on the molecular mechanism of epithelial ovarian cancer has been progressing，finding more factors affecting the prognosis of epithelial ovarian cancer and improving the survival rate of patients as a potential therapeutic target.